The National Administration of Drugs, Foods and Medical Technology (ANMAT) has renewed FP Clinical Pharma S.R.L.'s Authorization to conduct Phase IV Clinical Pharmacology Bioequivalence Studies in the adult population.
We are ready to take on your next bioequivalence project!
View file (PDF)On 01/20/2026, ANMAT Salud published Disposition 47/2026 in the Official Gazette, updating the list of APIs that must undergo bioequivalence/bioavailability studies.
Read moreDr. Ethel Feleder, our Director, was selected by ANMAT to join the Network of Experts in Pharmacological Clinical Research.
Read more
